The story of Sildenafil presents a complex picture for those considering investment. While the initial launch generated significant profits, the lapse of its exclusive rights opened the door to cheaper competitors, https://gatherbookmarks.com/story22617452/the-copyright-and-pharma-a-risky-opportunity